The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of bevacizumab and erlotinib as second line therapy for advanced hepatocellular carcinoma.
 
Ahmed Omar Kaseb
No Relationships to Disclose
 
Humaid Obaid Al-Shamsi
No Relationships to Disclose
 
Jeffrey Morris
No Relationships to Disclose
 
Michiko Iwasaki
No Relationships to Disclose
 
Lianchun Xiao
No Relationships to Disclose
 
Reham Abdel-Wahab
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
No Relationships to Disclose
 
Manal Hassan
No Relationships to Disclose
 
Hesham M. Hassabo
No Relationships to Disclose
 
Robert A. Wolff
Honoraria - Precision Medicine Research Associates, LLC
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC
Travel, Accommodations, Expenses - London Health Sciences Centre (LHSC)